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Purpose: The interpretation of genetic variants after genome-wide
analysis is complex in heterogeneous disorders such as intellectual
disability (ID). We investigate whether algorithms can be used to
detect if a facial gestalt is present for three novel ID syndromes and
if these techniques can help interpret variants of uncertain
significance.
Methods: Facial features were extracted from photos of ID
patients harboring a pathogenic variant in three novel ID genes
(PACS1, PPM1D, and PHIP) using algorithms that model human
facial dysmorphism, and facial recognition. The resulting features
were combined into a hybrid model to compare the three cohorts
against a background ID population.
Results: We validated our model using images from 71 individuals
with Koolen–de Vries syndrome, and then show that facial gestalts
are present for individuals with a pathogenic variant in PACS1 (p=
8 × 10−4), PPM1D (p= 4.65 × 10−2), and PHIP (p= 6.3 × 10−3).
Moreover, two individuals with a de novo missense variant of
uncertain significance in PHIP have significant similarity to the
expected facial phenotype of PHIP patients (p < 1.52 × 10−2).
Conclusion: Our results show that analysis of facial photos can be
used to detect previously unknown facial gestalts for novel ID
syndromes, which will facilitate both clinical and molecular
diagnosis of rare and novel syndromes.
Genetics inMedicine (2019) 21:1719–1725; https://doi.org/10.1038/s41436-
018-0404-y
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INTRODUCTION
Rare sporadic (de novo) pathogenic variants are a major
cause of developmental disorders such as intellectual
disability (ID) and autism spectrum disorders.1 Using
next-generation sequencing strategies, a disease-causing
genetic variant can now be identified in ~60% of individuals
with ID, and to date approximately 750 of the predicted
2000 genes causing ID have been identified.1–3 In 30–40% of
cases, ID is observed as part of a broader syndrome
consisting of facial dysmorphology in conjunction with
additional congenital abnormalities.4 In addition, we have
previously shown that individuals with ID who present with
facial dysmorphology are significantly enriched in both
pathogenic and likely pathogenic variants.5 Despite the
distinctive, although sometimes subtle facial features,
phenotyping of individuals with ID (and their parents)
currently relies on a clinician’s ability to recognize a
syndrome based on its related dysmorphology.
The implementation of high-throughput sequencing tech-
nologies such as exome sequencing has facilitated the ability
to detect individuals with increasingly rare novel disorders;2
this calls for novel methods for collecting phenotypic
information. Facial recognition and matching algorithms
have matured in recent years and can be exploited in a clinical
setting to automate and objectively measure a person’s
dysmorphology with minimal impact on the person.6–18 The
advantages of these methods are that they also include subtle
features that may be difficult for clinicians to identify or
recognize features that may not necessarily be considered
dysmorphic. Moreover, they can be used to identify additional
individuals with a known syndrome or aid the characteriza-
tion of novel ID syndromes. Alternatively, they can support
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the interpretation of variants for which functional impact may
be uncertain, such as missense variants in a gene known to
cause disease when mutated but for which clinical presenta-
tion is variable and/or includes a broad clinical spectrum. In
this study, we created a novel hybrid learning model for
detecting facial similarity within small subsets of individuals
with the same ID syndrome (n < 15) and compared them with
the general ID population. Our new model was able to
successfully detect facial similarity in all three examined novel
ID syndromes by incorporating both dysmorphic and generic
facial features from two different facial analysis algorithms in
combination with a unique collection of photos of control
individuals with ID.12,19 We show that our new hybrid model
is more sensitive than individual facial analysis algorithms
and that it can lead to novel clinical diagnosis for individuals
with missense variants of uncertain significance.
MATERIALS AND METHODS
Data collection
For this study one validation set and three test sets were
generated. Each set consisted of facial photos of individuals
with a specific ID syndrome and of matched ID controls. All
facial photographs used in the study were taken from an
approximately frontal position under uncontrolled condi-
tions. The majority of the individuals with a specific ID
syndrome used in this study are previously published cases. In
addition some novel unpublished cases were included. The
individuals selected as ID controls are previously unpublished
individuals who were enrolled in the study from routine
clinical diagnostics at the Department of Human Genetics at
the Radboud University Medical Center (Radboudumc). To
ensure anonymity all photographs were converted into
unidentifiable feature vectors before analysis. This study was
approved by the RadboudUMC under the realm of diagnostic
process.
Validation set
The validation set consisted of 71 facial photos of Caucasian
individuals with Koolen–de Vries syndrome (KdVS) (OMIM
ID 610443), a syndrome with relatively high number of
patients and a known facial gestalt. For each patient, one ID
control was selected matching in gender, ethnicity, and age
(measured in years) at the time of the photo. This resulted in a
validation set consisting of 71 individuals with KdVS and 71
matched ID controls. (Supplemental Table S1).
Test sets
Three test sets were collected, each containing photos of
Caucasian individuals with variants in a specific novel ID gene
(PACS1 [Schuurs–Hoeijmakers syndrome, OMIM 615009;
N= 14], PPM1D [OMIM 617450; N= 11], and PHIP [OMIM
612870; N= 16]) and matched ID controls. For each patient
five ID controls were selected matching in gender, ethnicity,
and age (measured in years) at the time of the photo. This
resulted in three separate test sets: (1) PACS1 test set
consisting of 14 individuals with Schuurs–Hoeijmakers
syndrome and 70 matched ID controls, (2) a PPM1D test
set consisting of 11 individuals with a pathogenic truncating
variant in the last or penultimate exon of PPM1D with 55
matched ID controls, and (3) a PHIP test set consisting of 16
individuals with a pathogenic variant in PHIP and 80
matched ID controls (Supplemental Table S2–S4).
The PACS1 individuals all had the identical pathogenic
de novo missense variant in PACS1 (NM_018026.2:c.607
C>T; p.[Arg203Trp]),20,21 the 11 PPM1D individuals all had
pathogenic truncating variants in the last or penultimate exon
of PPM1D (NM_003620.3) (ref. 22), whereas the individuals
with variants in PHIP (NM_017934.6) formed a more
heterogeneous population, consisting of frameshifts, non-
sense, splice site, and missense variants.23 The four PHIP
missense variant (of uncertain significance) patients and their
controls were excluded from the gestalt analysis of PHIP
patients and were separately analyzed in a later stage, to test if
their faces match the PHIP facial phenotype.
ID control population
The control population consisted of ID patients referred to
the clinical genetics center of the RadboudUMC, Nijmegen
due to unexplained ID without a clearly recognizable
syndromic form of ID. From these ID patients, 15% had a
definitive genetic diagnosis, a possible cause was identified in
24% of cases (e.g., a variant of uncertain significance), and for
61% of the control cohort the genetic cause remained
unknown. Instead of using healthy control, ID controls were
used to examine if we can distinguish a specific ID syndrome
from the general ID population on the basis of facial features.
As described above, controls were selected to match the
patient in gender, ethnicity, and age (measured in years) at the
time of the photo. Of all patients in the validation and test
sets, 86% had corresponding controls that were an exact age
match, whereas for the remaining 14% perfect age matches
were not available and the closest available ages were selected
(Supplemental Table S1–S4). Patients were excluded from the
study if the age difference between patient and control was
greater than one-third of the patient’s age.
Feature extraction
A hybrid face description vector was extracted for each
portrait photo by combining the output of two computer
vision algorithms: the Clinical Face Phenotype Space
(CFPS)12 and OpenFace.19 Both these pipelines analyze a
portrait photo to extract a feature vector describing the facial
characteristics. In brief, the CFPS pipeline12 first uses face
detection, landmark annotation, and shape and appearance
extraction to obtain a face representation and transforms this
face representation into a 340-dimensional feature vector that
represents the patient’s facial features. The resulting space
places two individuals closer together if they have similar
dysmorphic features and farther apart if they do not. The
OpenFace pipeline19 is a system designed for facial recogni-
tion. It uses face detection, landmark annotation, and affine
transformation to convert a portrait photo into a standardized
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96 × 96 pixel image. This image is then used as input for a
pretrained facial recognition deep neural network of which
the output is a 128-dimensional feature vector that describes
the facial characteristics relevant to facial recognition. It
creates an abstract space in which people with similar faces
are located closer together, while people with dissimilar faces
are located farther apart.
We applied both the CFPS and OpenFace pipeline to our
KdVS, PACS1, PPM1D, and PHIP data sets, resulting in two
feature vectors for each photo. Because both feature extraction
methods are trained for a different purpose they are sensitive
to different facial features. The two feature vectors are then
combined into one hybrid vector, thus incorporating
dysmorphic information as well as general facial character-
istics. Before combining the vectors, normalization was
applied to give both models an equal weight. The mathema-
tical expression for the resulting hybrid feature vector is
described by
Hybrid feature vector ¼ f o
f o




2
f C
f C




2
" #
Where fO is the 128-dimensional OpenFace feature vector, fC
is the 340-dimensional CFPS feature vector, and zk k2 is the
Euclidean norm of z. This process results in one 468-
dimensional hybrid feature vector describing the facial
features for each individual in the data sets.
Gestalt analysis
The similarity between patients with the same novel ID
syndrome was analyzed by calculating the clustering improve-
ment factor (CIF) for each of the four novel ID syndromes,
using the patients as positives and the controls as negatives.
The CIF gives an estimate of the search space reduction.12 In
summary, the CIF estimates how well a group of positives
(e.g., patients) cluster within a group of negatives (e.g., the
controls) compared with what would be expected by random
chance. The CIF is calculated by determining for each positive
(e.g., patient), the rank of the nearest other positive (e.g.,
patient) and then comparing the average of these observed
ranks O(r) to the expected rank of the nearest other positive E
(r). And described by
CIF ¼ EðrÞ
OðrÞ
Where the expected rank is described as
E rð Þ ¼ 1þ
XNn
j¼1
1 j
Nn þ 1
 Np1
And where Nn is the number of negative instances and Np is
the number of positive instances.
After determining the CIF for each syndrome we randomly
labeled (while maintaining the patient–control ratio) the
patients and controls in each data set 10,000 times and
calculated the corresponding CIF for every permutation. For
each syndrome a right-tailed Mann–Whitney U test was
performed to determine if the CIF for the syndrome is
significantly higher than expected by random chance. This
process is performed for each of the three feature types: CFPS,
OpenFace, and hybrid. We also compared the performance of
these feature types on smaller numbers of patients. For this
purpose, we calculated the CIF for each possible combination
of N patients in each test set. Then we compared the median
CIF of all possible combinations with the CIFs for 1000
random permutations for each N as described above. In
addition, the distribution of the hybrid feature vectors of the
patients and controls are visualized for each data sets using t-
distributed stochastic neighbor embedding (t-SNE) to reduce
dimensionality.
Additionally, an experiment was performed to evaluate the
effect that the number of patients versus controls had on the
resulting CIF and p values. For each test set the corresponding
controls were divided into five disjoint subsets resulting in
subsets containing one matched ID control for each patient in
the test set, thus matching the patient-to-control ratio used
in the validation set. Then across each syndrome the CIF and
p value were calculated for each of the five control subsets
using the hybrid model and evaluated via the mean p value
and resulting confidence interval.
RESULTS
To examine whether a similar facial gestalt is present within
three novel ID syndromes using computational analysis, we
propose a descriptive facial feature vector that combines the
OpenFace and CFPS feature vector. Next, we calculated the
CIF to detect significant similarity. The CIF is a factor that
estimates how well the patients cluster within the group of
controls.
Model validation using a known syndrome
We first validated our model on patients with KdVS
syndrome, which is known to have associated and consistent
facial dysmorphology, including a long hypotonic face and a
bulbous nasal tip.24 The CFPS, OpenFace, and hybrid feature
vectors were extracted and compared between the 71 KdVS
patients and their age- and gender-matched controls. The
faces of the KdVS patients had a higher CIF than expected by
random chance, both when using the CFPS (CIF= 0.993, p=
4.26 × 10−2) and the OpenFace (CIF= 1.143, p= 2 × 10−4)
features, meaning both feature types can detect the facial
similarity in KdVS patients. Our novel hybrid feature vector
also showed a higher CIF than expected by random chance
(CIF= 1.191, p < 1 × 10−4). The CIF for the hybrid model is
higher than for the individual feature types, indicating an
improvement in clustering when combining the two feature
vectors (Table 1).
Model application to novel ID syndromes
We performed a similar analysis for the three novel ID
syndromes, with five age-matched controls per patient, using
either the CFPS, OpenFace, or our novel hybrid model to
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describe the facial characteristics. Using only the CFPS
features significant similarity was detected for PACS1 (CIF=
1.908, p= 1.90 × 10−2) and PHIP (CIF= 2.399, p= 7.1 ×
10−3), but not for PPM1D (CIF= 1.011, p= 4.77 × 10−1).
Using the OpenFace features found significant similarity for
PACS1 (CIF= 1.955, p= 7.6 × 10−3) and PPM1D (CIF=
1.667, p= 4.80 × 10−2), but not for PHIP (CIF= 1.101, p=
3.20 × 10−1). Our novel hybrid model was the only model that
showed significant facial similarity for all three syndromes:
PACS1 (CIF= 2.523, p= 8 × 10−4), PPM1D (CIF= 1.713,
p= 4.65 × 10−2), and PHIP (CIF= 2.239, p= 6.3 × 10−3)
(Table 1). For all three novel ID genes the highest significance
was achieved when using the hybrid feature vectors. A t-SNE
plot of the different test sets illustrates the similarity between
the patients with the same syndrome compared with the
matched ID control population using our novel hybrid model
(Fig. 1).
Application to missense variants of uncertain significance
We examined whether the four patients with a de novo
missense variant in the PHIP gene (individual A:
NM_017934.6:c.328C>T, individual B: NM_017934.6:
c.328C>A, individual C: NM_017934.6:c.1562A>G, and
individual D: NM_017934.6:c.2888A>G) show significant
similarity to the 12 individuals with a presumed loss-of-
function variant in PHIP. When visualizing the complete
PHIP data set, we observed that all four missense patients
were located in the vicinity of the other PHIP patients.
Individuals A and D displayed a stronger association to other
PHIP patients compared with individuals B and C (Fig. 1c).
To quantify this, we compared the Euclidean distance from
the hybrid feature vectors of the missense patients with their
nearest PHIP patient with the Euclidean distances between
the controls and their nearest PHIP patient using a right-
tailed Mann–Whitney U test (Table 2). The distance from
Table 1 Overview of the statistical analysis on the presence of a facial gestalt for the four ID syndromes using the three
described models (one-sided Mann–Whitney U test)
Data set Model CIF Median CIF
simulations
U statistic p value
Koolen–de Vries syndrome CFPS 0.993 0.8026 389 4.26 × 10−2a
OpenFace 1.143 0.8026 1 2 × 10−4a
Hybrid 1.191 0.8026 0 <1 × 10−4a
PACS1 CFPS 1.908 0.9656 172 1.90 × 10−2a
OpenFace 1.955 0.9538 68 7.6 × 10−3a
Hybrid 2.523 0.9538 5 8 × 10−4a
PPM1D CFPS 1.011 0.9788 4683.5 4.77 × 10−1
OpenFace 1.667 0.9635 442 4.80 × 10−2a
Hybrid 1.713 0.9635 422.5 4.65 × 10−2a
PHIP CFPS 2.399 0.9736 59.5 7.1 × 10−3a
OpenFace 1.101 0.9597 3098 3.20 × 10−1
Hybrid 2.239 0.9597 54 6.3 × 10−3a
CIFclustering improvement factor, CFPS Clinical Face Phenotype Space, ID intellectual disability.
aStatistically significant difference.
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Fig. 1 Distribution of the hybrid facial features in the PACS1, PPM1D, and PHIP data sets. The t-distributed stochastic neighbor embedding (t-SNE)
plots of the (a) PACS1, (b) PPM1D, and (c) PHIP data set analyzed using our novel hybrid model show that faces of patients with the same novel intellectual
disability (ID) syndrome are located close together within a group of age-, gender-, and ethnicity-matched controls. Four individuals with a missense variant
of uncertain significance in the PHIP gene are compared with 12 individuals with a presumed loss-of-function variant in PHIP, showing significant similarity to
the PHIP facial phenotype for individuals A and D.
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individuals A and D to the nearest PHIP patient was
significantly smaller than expected by random chance (both
p < 1.52 × 10−2), thus showing that the facial phenotypes of
individuals A and D are significantly similar to the facial
phenotype of other PHIP patients. Whereas individuals B and
C were not significantly closer to other PHIP patients than
expected by random chance (p= 1.82 × 10−1 and p= 6.06 ×
10−2 respectively).
DISCUSSION
The development of the face and the brain are tightly linked
and craniofacial anomalies are reported in 30–40% of
individuals with ID.4 This link has been used in clinical
setting for decades to establish a syndromic diagnosis in
individuals with ID. Developments in facial phenotyping
through computational analysis of facial images have shown
that it is possible to train an algorithm to recognize patients
with a number of known dysmorphic syndromes.6–18 In this
study we used facial image analysis to answer two different
questions, namely (1) is there a shared facial gestalt present
for a novel ID syndrome without clear clinically recognizable
facial features, and (2) do patients with a variant of uncertain
significance exhibit significant facial similarity to patients
with a pathogenic variant within the same gene. To answer
these questions, in contrast to previous studies, we used a
background control set of individuals with ID, and not
healthy individuals. Thereby presenting the algorithm with a
relevant classification problem close to the clinical question,
namely to recognize subgroups of individuals within the ID
population. In addition, we matched the controls to exclude
age-, gender-, or ethnicity biases.
Information contained in human faces can be used in
the delineation of genetic entities.18 For this reason, we
selected four different cohorts of individuals with
syndromes caused by different pathophysiological
mechanisms. Firstly, for validation purposes we selected
a large cohort of KdVS patients representing a homo-
geneous set of patients with loss-of-function variants
correlating to a known syndrome with dysmorphic
features. Our model also showed that the faces of
individuals with KdVS were significantly similar when
compared with the general ID population. Similarly
the patients with a de novo PACS1 variant represent a
cohort in which all members had an identical pathogenic
de novo variant in PACS1 (NM_018026.2:c.607C>T;
p.[Arg203Trp])20,21 and for which computational analysis
had recently been performed on a subset of the individuals
showing that a facial gestalt is present.12,16 Notably in
comparison with the first two index patients, the facial
phenotype has broadened as the cohort has expanded, and
more variation has been introduced while still showing
that significant facial similarity exists between individuals
(Supplemental Figure S1). Our model achieved higher CIF
values for the test cohorts compared with the validation
cohort, in part due to the difference in patient-to-control
ratio, which results in a higher maximum achievable CIF.
Retrospective analysis illustrated that selecting one matched
ID control per test subject influenced the resulting CIF values
and had insufficient power to generate statistically robust
results (Supplemental Table S5). The last two cohorts consist
of patients without a clearly clinically recognizable facial
dysmorphology; PPM1D patients all had pathogenic truncat-
ing variants in the last or penultimate exon of PPM1D
(NM_003620.3) (ref. 22) and the cohort of PHIP patients had
variants (NM_017934.6) consisting of loss-of-function var-
iants (frameshifts, nonsense, splice sites) leading to haploin-
sufficiency.23 This final cohort of PHIP patients allowed us to
test the ability to classify patients with a de novo missense
variant of uncertain significance within the clinical context of
the remainder of PHIP patients with a presumed loss-of-
function variant. The pathophysiological effect of a missense
variant is often less clear than that of truncating variants. Our
analysis helped interpret the phenotypic effect of two of four
missense variants, demonstrating in two individuals (A and
D) significant similarity to other PHIP patients with a loss-of-
function variant. Whereas individuals B and C showed a trend
toward facial similarity, which may become significant with a
larger cohort of PHIP individuals.
While choosing not to retrain the algorithms, our model
does combine the CFPS feature space trained to recognize
dysmorphic features in patients with the features from
OpenFace trained to perform face recognition. We show that
the two feature spaces are sensitive to different characteristics
and only their combined power was able to detect the
sometimes-subtle features within our small patient cohorts
(Supplemental Figure S2). For example, CFPS detected
similarity in the PHIP patient group, whereas OpenFace
detected similarity in the PPM1D patient group. This most
likely reflects the more distinct facial features of individuals
Table 2 Overview of the statistical analysis on the facial
similarity between individuals with a missense variant of
uncertain significance in the PHIP gene and individuals with
a presumed loss-of-function variant in the PHIP gene (one-
sided Mann–Whitney U test)
ID Distance to
nearest
PHIP
patient
Median distance of
controls to nearest
PHIP patient
U
statistic
p value
Individual
A
1.147 1.557 0 <1.52 ×
10−2a
Individual
B
1.390 1.557 11 1.82 ×
10−1
Individual
C
1.300 1.554 3 6.06 ×
10−2
Individual
D
1.138 1.557 0 <1.52 ×
10−2a
aStatistically significant difference.
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with a pathogenic variant in PHIP compared with the subtler
facial features of individuals with a pathogenic PPM1D
variant. The disadvantage of both models is that it results in
an abstract representation of the face and it is difficult to
translate the results of the classification back to individual
facial features and hence underlying biology. However,
computer-based models do perform objective facial analysis,
compared with the more subjective interpretations of
clinicians. One challenge that needs to be faced in future
research is the comparison of facial features between patients
with different ethnicities.25–29
In conclusion we present a model that combines a facial
recognition algorithm with an algorithm trained to
recognize dysmorphic features. We show that patients with
a pathogenic variant in one of three novel ID genes (PACS1,
PPM1D, and PHIP), identified via genotype-first approach,
have an associated facial gestalt, thus demonstrating that
information contained in the face can be used to delineate
genetic entities including in novel ID syndromes with no
previously known knowledge of a facial phenotype. Notably
our model provides significant results with a small number
of patients (n < 15) and provides a phenotypic readout to
interpret variants of uncertain significance. The implemen-
tation of next-generation sequencing in the clinic has
resulted in the identification of increasingly rare syn-
dromes, and the orthogonal use of computational analysis
of facial features will be key for linking variants to patients’
novel and yet unknown phenotypes leading to a clinical
diagnosis.
URLS
CADD http://cadd.gs.washington.edu/ Clinical Face Phenotype
Space https://github.com/ChristofferNellaker/Clinical_Face_
Phenotype_Space_Pipeline OpenFace https://cmusatyalab.
github.io/openface/
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